| Status | Suspended |
| Process | STA pre-2018 |
| Referral date | 01 August 2015 |
Provisional Schedule
| Closing date for invited submissions / evidence submission: | TBC |
| 1st appraisal committee meeting: | TBC |
Project Team
| Associate Director: | Helen Knight |
| Communications manager: | TBC |
| Project manager: | Kate Moore |
| Technical Advisor: | TBC |
| Technical Lead: | TBC |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 25 September 2015 | This appraisal has formally started now, in line with the anticipated regulatory timelines. However, the manufacturer of paclitaxel has informed us that they will not provide an evidence submission for this appraisal. NICE has therefore suspended this appraisal and we will provide further updates when they are available. |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance